19 Tips for Finding...
Health Care: Drugs
Dynavax Technologies Corporation (DVAX: NASDAQ)
$3.56 -0.05 | -1.38%
06/04/12 - 09:45 AM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 279,998 | 204,998 | 530,982 | 325,984 | 325,984 | -535,315 | -535,315 |
| Shares Bought | 279,998 | 204,998 | 574,998 | 370,000 | 370,000 | 49,008 | 49,008 |
| Shares Sold | 0 | 0 | 44,016 | 44,016 | 44,016 | 584,323 | 584,323 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 128.07M | 125.63M | 125.83M | 124.90M | 94.53M | 94.53M | 94.53M |
| Shares Bought | 22.21M | 52.20M | 46.69M | 43.14M | 20.83M | 20.83M | 20.83M |
| Shares Sold | 15.60M | 8.10M | 9.81M | 9.79M | 4.52M | 4.52M | 4.52M |
Portfolios with DVAX
- Portfolio NameUser Type
- Contributor10 Stocks Boosting Little F...
- UserMy stocks
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
- ContributorStocks At New 52-Week Highs...
- Contributor13 Biotech Stocks Bought an...
- Contributor10 Pharma Stocks Under $3
- Contributor4 Biotech Penny Stocks to Buy
- UserMy Portfolio
- UserStarters
Latest DVAX Headlines from TheStreet
- Dynavax Stock Gaps Down On Today's Open (DVAX) 05.09.12 | 09:05 am
- 10 Stocks Boosting Little Funds to Big Returns (Update2) 03.16.12 | 02:03 pm
- 8 Stocks Under $10 Moving Higher 02.02.12 | 02:02 pm
- 10 Stocks of Top-Performing Funds in 2012 01.20.12 | 10:01 am
- Biotech Calendar: Key Dates for October 10.03.11 | 08:10 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- Dynavax Stock Gaps Down On Today's Open (DVAX) 07.20.11 | 09:07 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
- 4 Biotech Penny Stocks to Buy: Navellier 04.13.11 | 11:04 am
- Dynavax, Frontier Financial: Early Volume Plays 04.27.10 | 07:04 am
Press Releases for DVAX
Partner Headlines for DVAX
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
- Dynavax Announces $30 Million Common Stock Purchase (DVAX) - Benzinga 09.20.10 | 04:09 pm
- UPDATE 1-Dynavax posts Q2 loss, shares fall - Reuters 07.30.10 | 05:07 pm
- UPDATE 1-Dynavax's flu vaccine shows promise, shares rise - Reuters 04.26.10 | 05:04 pm
- Healthcare, Technology Converge: Recent Biotech Deals - SeekingAlpha.com 04.19.10 | 05:04 am
- UPDATE 1-Dynavax hep B vaccine shows promise in kidney disease - Reuters 04.14.10 | 05:04 pm
